Many reported cost saving results although one randomised controlled trial reported no significant effects [ 21].
The trial reported Wednesday involved 58 men with localized high-risk disease.
In the on-site trial reported here, M-distance values were well above 3.
One trial reported that fluid intake was detrimental to performance [66].
That trial reported promising initial results in 2011, cutting rates of malaria by half in toddlers.
One prospective trial reported benefits with addition of DEX to BZD therapy in patients with DT [16].
The Acute Neurosurgical ICU Sedation Trial reported that sedation with dexmedetomidine improved the cognitive score compared with propofol [17].
One trial reported on groups with bipolar disorders and unipolar disorders that were randomized separately (Kane et al. [1982]).
A third trial reported better outcomes for the combination of atorvastatin with interferon-β [13].
Neither trial reported any deaths.
One trial reported complete outcome measures [ 22].
